Literature DB >> 9075580

Structure-function relationships of the complement regulatory protein, CD59.

J Petranka1, J Zhao, J Norris, N B Tweedy, R E Ware, P J Sims, W F Rosse.   

Abstract

CD59 (membrane inhibitor of reactive lysis, protectin) is a membrane protein whose functions include the inhibition of the insertion of the ninth component of complement into the target membrane. It belongs to a superfamily of proteins including Ly-6, elapid snake venom toxins, and urokinase receptor (UPAR); the members of the superfamily have a similar structure that includes four (in mammals five) disulfide bridges that maintain a three-dimensional conformation consisting of a central core, three finger-like "loops" extending from it and a small loop near the coboxyl end. We have used site directed mutagenesis to explore three aspects of the structure of CD59: 1) the role of the disulfide bridges in expression and function of the molecule; 2) the location of epitopes reacting with monoclonal antibodies to the molecule; and 3) the parts of the molecule that are critical to its function in inhibiting complement lysis. Mutant molecules in which the disulfides maintaining the finger-like loops (Cys3-Cys26, Cys19-Cys39, and Cys45-Cys63) were removed were not expressed on the cell surface. The mutation of the disulfide (Cys6-Cys13) resulted in no change in expression or function. The mutation of Cys64-Cys69 maintaining the small loop resulted in an expressed molecule with increased functional activity. The major epitope for 6 of 7 monoclonal antibodies was centered on Arg53 as the mutation 53Arg-->Ser resulted in a loss of interaction with these antibodies, as did the deletion of four nearby residues (Leu54-Asn57). The alteration 55Arg-->Ser resulted in loss of reactivity for some but not other antibodies. The reactivity with one monoclonal antibody, H19, was abrogated by the mutations 61Tyr-->Gly and 61Tyr-->Ala. Functional activity of the molecule was not adversely altered by mutations in the first and second loops; however, the 61Tyr-->Gly mutation was non-functional. The mutation of 61Tyr-->His diminished function but changes 61Tyr-->Ala and 61Tyr-->Phe had no effect on function. We conclude that the functional site of CD59 is located in this region of the molecule.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9075580     DOI: 10.1006/bcmd.1996.0111

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  10 in total

1.  Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

Authors:  Julie M Leth; Haydyn D T Mertens; Katrine Zinck Leth-Espensen; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

2.  Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding.

Authors:  Christopher M Allan; Cris J Jung; Mikael Larsson; Patrick J Heizer; Yiping Tu; Norma P Sandoval; Tiffany Ly P Dang; Rachel S Jung; Anne P Beigneux; Pieter J de Jong; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2017-05-05       Impact factor: 5.922

3.  Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.

Authors:  Stephanie E Wickham; Eileen M Hotze; Allison J Farrand; Galina Polekhina; Tracy L Nero; Stephen Tomlinson; Michael W Parker; Rodney K Tweten
Journal:  J Biol Chem       Date:  2011-04-20       Impact factor: 5.157

4.  Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.

Authors:  Remco Franssen; Stephen G Young; Frank Peelman; Jozef Hertecant; Jeroen A Sierts; Alinda W M Schimmel; André Bensadoun; John J P Kastelein; Loren G Fong; Geesje M Dallinga-Thie; Anne P Beigneux
Journal:  Circ Cardiovasc Genet       Date:  2010-02-02

5.  Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.

Authors:  Line V Hansen; Henrik Gårdsvoll; Boye S Nielsen; Leif R Lund; Keld Danø; Ole N Jensen; Michael Ploug
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

6.  Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase.

Authors:  Anne P Beigneux; Peter Gin; Brandon S J Davies; Michael M Weinstein; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

7.  High-resolution structures of bacterially expressed soluble human CD59.

Authors:  Kirstin J Leath; Steven Johnson; Pietro Roversi; Timothy R Hughes; Richard A G Smith; Lloyd Mackenzie; B Paul Morgan; Susan M Lea
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-28

Review 8.  Evolution and Medical Significance of LU Domain-Containing Proteins.

Authors:  Julie Maja Leth; Katrine Zinck Leth-Espensen; Kristian Kølby Kristensen; Anni Kumari; Anne-Marie Lund Winther; Stephen G Young; Michael Ploug
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

9.  LY6D-induced macropinocytosis as a survival mechanism of senescent cells.

Authors:  Taiki Nagano; Tetsushi Iwasaki; Kengo Onishi; Yuto Awai; Anju Terachi; Shione Kuwaba; Shota Asano; Ryoko Katasho; Kiyoko Nagai; Akio Nakashima; Ushio Kikkawa; Shinji Kamada
Journal:  J Biol Chem       Date:  2020-11-24       Impact factor: 5.157

10.  Determination of the Membrane Environment of CD59 in Living Cells.

Authors:  Gergő Fülöp; Mario Brameshuber; Andreas M Arnold; Gerhard J Schütz; Eva Sevcsik
Journal:  Biomolecules       Date:  2018-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.